-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The World Health Organization recently released the report of the "World Health Organization Expert Evaluation Meeting on the Treatment of New Coronary Pneumonia with Traditional Chinese Medicine"
.
The meeting evaluated the clinical application, research and evidence-based evaluation reports provided by the Chinese expert group
.
The final report of the meeting pointed out that traditional Chinese medicine can effectively treat new coronary pneumonia and reduce the conversion of mild and common cases to severe cases; for mild and common cases, compared with simple conventional treatment, traditional Chinese medicine can be used as an additional intervention.
Shorten the time of virus clearance, clinical symptom relief and hospital stay; the report also recommends that member states consider incorporating traditional Chinese medicine into the clinical management planning of COVID-19 in their health systems and regulatory frameworks; encourages member states to consider using China’s integrated traditional Chinese and Western medicine model, promote International clinical trials
.
.
The meeting evaluated the clinical application, research and evidence-based evaluation reports provided by the Chinese expert group
.
The final report of the meeting pointed out that traditional Chinese medicine can effectively treat new coronary pneumonia and reduce the conversion of mild and common cases to severe cases; for mild and common cases, compared with simple conventional treatment, traditional Chinese medicine can be used as an additional intervention.
Shorten the time of virus clearance, clinical symptom relief and hospital stay; the report also recommends that member states consider incorporating traditional Chinese medicine into the clinical management planning of COVID-19 in their health systems and regulatory frameworks; encourages member states to consider using China’s integrated traditional Chinese and Western medicine model, promote International clinical trials
.
